LES electrical simulation therapy has shown to improve outcomes in GERD patients.AIM: To evaluate the safety and efficacy of LES stimulation in LSG patients with GERD not controlled with maximum dose PPI therapy.The Mummy is a 1999 American action horror film written and directed by Stephen Sommers and starring Brendan Fraser (pictured), Rachel Weisz, John Hannah, Kevin J. In this film, a loose remake of a film of the same name from 1932, adventurers accidentally awaken Imhotep, a high priest from Pharaoh Seti I's reign who has been cursed for eternity.Filming began in Marrakesh, Morocco, in May 1998; the crew had to endure dehydration, sandstorms, and snakes while filming in the Sahara.Long-term clinical results of Endo Stim patients treated for up to five years shows that LES stimulation is safe and effective in controlling GERD symptoms and improving patient quality of life in most patients.Most patients experience: BACKGROUND: LSG is the most commonly performed bariatric procedure in the US/Canada and the Asia-Pacific region.CONCLUSION: Preliminary results on patients with LSG and GERD with bothersome symptoms despite maximal medical therapy, treated with LES electrical stimulation, revealed that LES stimulation is safe and results in a significant improvement in GERD symptoms and esophageal acid exposure.
heartburn, regurgitation, sleep disruption) as part of a validated questionnaire for the diagnosis of GERD (Gerd Q). Data from routine clinical practice has not yet been reported.
No SAEs related to the device or procedure were reported.
No dysphagia or other GI side effects were reported.
View Full Article BACKGROUND: We have previously reported that LES-EST has improved in outcomes in patients with GERD at 3 year follow-up (Surg Endosc. AIM: The aim of this open-label human pilot trial registry was to study the safety and efficacy of LES-EST in the cohort of GERD patients over longer 5-year follow-up. METHODS: GERD patients at least partially responsive to proton pump inhibitors (PPI) and had off-PPI GERD HRQL50% of days with PPI use).
There were no unanticipated device- or stimulation-related adverse events, or untoward sensation reported between 3 and 4 year follow-up.